Utilization of an Amorphous Form of a Water-Soluble GPIIb/IIIa Antagonist for Controlled Release from Biodegradable Microspheres

This publication has 11 references indexed in Scilit:

• Characteristics and Significance of the Amorphous State in Pharmaceutical Systems
  Journal of Pharmaceutical Sciences, 1997
• Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.
  1996
• Application of a spray drying technique in the production of TRH-containing injectable sustained-release microparticles of biodegradable polymers.
  1995
• Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
  New England Journal of Medicine, 1994
• MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man.
  Circulation, 1993
• ONE-MONTH RELEASE INJECTABLE MICROCAPSULES OF A LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST (LEUPROLIDE ACETATE) FOR TREATING EXPERIMENTAL ENDOMETRIOSIS IN RATS
  1988
• Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: Influence of molecular weight and copolymer ratio of polymer.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
• The Preparation and Evaluation of Drug-Containing Poly(dl-lactide) Microspheres Formed by the Solvent Evaporation Method
  Pharmaceutical Research, 1987
• Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.
  Proceedings of the National Academy of Sciences, 1984
• Controlled Release of a Luteinizing Hormone-Releasing Hormone Analogue from Poly(d,l-lactide—co-glycolide) Microspheres
  Journal of Pharmaceutical Sciences, 1984